Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-06

Clinical Trial Update: The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS) [Phase 3]

View source ↗

Summary

A Phase 3 trial (completed) evaluating three uterotonic options—oxytocin, carbetocin, and buccal misoprostol—in patients undergoing elective cesarean section. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buccal misoprostol (misoprostol)
  • Carbetocin (carbetocin)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Ain Shams University | Conditions: Postpartum Hemorrhage | Phase 3 | Status: COMPLETED